Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether patients with asthma who carry a genotype
associated with adverse outcomes with long-acting beta-2 agonists like salmeterol show
greater benefit from the use of an asthma drug that works via alternative pathways like
montelukast.